北美注射笔市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(一次性注射笔和可重复使用注射笔)、治疗(糖尿病、生长激素治疗、自身免疫性疾病、生育力、癌症和其他治疗)和结束用户(医院和诊所、家庭护理等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 130    |    Report Code: BMIRE00028198    |    Category: Life Sciences

North America Injection Pen Market

北美注射笔市场预计将从2022年的131.566亿美元增长到2028年的200.7551亿美元。预计2022年至2028年的复合年增长率为7.3%。< /strong>

 

加大北美注射笔市场的战略发展

 

注射笔市场的特点是市场参与者众多。为了增加市场份额,市场参与者采取各种策略,例如产品发布、区域扩张和技术进步。注射笔更多地涉及持续创新和技术进步,导致行业参与者的接受度不断提高。领先企业投资研发以开发先进技术并获得更多收入。

以下是与注射笔相关的一些最新进展:

2022 年 5 月,FDA 批准了礼来公司的 Mounjaro 注射液,这是第一个也是唯一一个葡萄糖依赖性促胰岛素多肽 (GIP) 和胰高血糖素样肽 1 (GLP-1) 受体激动剂,用于治疗 2 型糖尿病成年人。 Mounjaro 有六种剂量(2.5 毫克、5 毫克、7.5 毫克、10 毫克、12.5 毫克和 15 毫克),采用礼来公司完善的自动注射笔,配有预装隐藏针头。

2022 年 1 月,SHL Medical 与 Innovation Zed 合作开发互联笔式注射器解决方案。它推出了 InsulCheck DOSE,这是一种连接的附加设备,可将传统笔式注射器转变为智能解决方案,以支持疾病管理方案的监测。

2021 年 5 月,礼来公司与领先的糖尿病技术公司为糖尿病患者集成互联胰岛素笔解决方案。公司与四家公司签署战略国际协议——DexCom, Inc.;格洛克公司;我的迪亚比医疗保健;和罗氏共同推进互联解决方案并简化糖尿病患者的护理。

所有上述最新发展都正在推动北美注射笔市场的发展。

 

北美注射笔市场概况

 

< p>北美注射笔市场分为美国、加拿大和墨西哥。该地区的市场增长归因于糖尿病和不孕症发病率的增加以及市场产品开发的不断增加。根据美国糖尿病协会的数据,2019年美国糖尿病患者人数达到3730万(占总人口的11.3%)。美国近190万人口患有1型糖尿病,其中包括约244,000名儿童和青少年。此外,美国每年诊断出约 140 万糖尿病病例。根据美国疾病控制与预防中心的数据,2020 年,约 8800 万成年人患有糖尿病前期,占美国成年人口的 34.5%。据耶鲁大学研究人员称,到 2022 年,约 3000 万美国人口患有糖尿病,约 700 万人需要每日胰岛素。

美国对不孕不育治疗的需求不断增加美国。例如,根据疾病预防控制中心的数据,2019 年,美国 15 岁至 44 岁的男性中有 9% 的男性和女性有 10% 的女性存在不孕问题。

 

< h3>

到 2028 年北美注射笔市场收入及预测(百万美元)

                   

 

北美注射笔市场细分

 

北美注射笔市场根据类型、治疗方法、最终用户进行细分和国家。根据类型,注射笔市场分为一次性注射笔和可重复使用注射笔。一次性注射笔细分市场在 2022 年占据了更大的市场份额。

 

根据治疗,北美注射笔市场细分为< span>糖尿病治疗、生长激素治疗、自身免疫性疾病治疗、生育治疗、癌症治疗等。糖尿病治疗细分市场在 2022 年占据最大市场份额。

 

根据最终用户,北美注射笔市场细分为 <医院及医院诊所、家庭护理等。家庭护理细分市场在 2022 年占据最大市场份额。

 

根据国家/地区,北美注射笔市场细分为美国、加拿大和墨西哥。美国在 2022 年占据市场主导地位。

 

阿斯利康公司 (AstraZeneca Plc)、碧迪金森公司 (Becton Dickinson and Co)、礼来公司 (Eli Lilly and Co)、Gerresheimer AG、Haselmeier GmbH、 Merck KGaA、Novo Nordisk AS、Owen Mumford Ltd、Sanofi SA 和 Teva Pharmaceutical Industries Ltd 是北美注射笔市场的领先公司。



North America Injection Pen Strategic Insights

Strategic insights for North America Injection Pen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-injection-pen-market-strategic-framework.webp
Get more information on this report

North America Injection Pen Report Scope

Report Attribute Details
Market size in 2022 US$ 13,156.60 Million
Market Size by 2028 US$ 20,075.51 Million
Global CAGR (2022 - 2028) 7.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 一次性注射笔
  • 可重复使用注射笔
By 治疗
  • 糖尿病
  • 生长激素治疗
  • 自身免疫性疾病
  • 生育
  • 癌症
  • 其他治疗
By 最终用户
  • 医院和诊所
  • 家庭护理
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Get more information on this report

    North America Injection Pen Regional Insights

    The regional scope of North America Injection Pen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-injection-pen-market-geography.webp
    Get more information on this report

    The List of Companies - North America Injection Pen Market

    1. AstraZeneca Plc
    2. Becton Dickinson and Co
    3. Eli Lilly and Co
    4. Gerresheimer AG
    5. Haselmeier GmbH
    6. Merck KGaA
    7. Novo Nordisk AS
    8. Owen Mumford Ltd
    9. Sanofi SA
    10. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the North America Injection Pen Market?

    The North America Injection Pen Market is valued at US$ 13,156.60 Million in 2022, it is projected to reach US$ 20,075.51 Million by 2028.

    What is the CAGR for North America Injection Pen Market by (2022 - 2028)?

    As per our report North America Injection Pen Market, the market size is valued at US$ 13,156.60 Million in 2022, projecting it to reach US$ 20,075.51 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.

    What segments are covered in this report?

    The North America Injection Pen Market report typically cover these key segments-

  • 类型 (一次性注射笔, 可重复使用注射笔)
  • 治疗 (糖尿病, 生长激素治疗, 自身免疫性疾病, 生育, 癌症, 其他治疗)
  • 最终用户 (医院和诊所, 家庭护理)
  • What is the historic period, base year, and forecast period taken for North America Injection Pen Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Injection Pen Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Injection Pen Market?

    The North America Injection Pen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Who should buy this report?

    The North America Injection Pen Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Injection Pen Market value chain can benefit from the information contained in a comprehensive market report.